We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

Siemens Acquires PETNet Manufacturing Center

By HospiMedica staff writers
Posted on 10 Mar 2006
Siemens Medical Solutions (Erlangen, Germany) with its subsidiary PETNet Pharmaceuticals, Inc. More...
(Knoxville, TN, USA), has acquired full ownership of New England PETNet Manufacturing & Distribution Center, LLC (Woburn, MA, USA). Financial details were not disclosed.

The acquisition, a result of continuing efforts of expansion, enables Siemens and PETNet to provide biomarkers for clinical and preclinical positron emission tomography (PET) imaging to the U.S's New England region through PETNet's SafetyNet international network of more than 45 manufacturing and distribution centers. PETNet, Siemens' distribution channel for biomarkers, is the world's leading producer and distributor of PET biomarkers, with the largest U.S. network of cyclotron-equipped radiopharmacies.

"In addition to biomarker delivery and solutions for the research and clinical markets, PETNet customers in the New England region will have access to an array of programs to support and enable the continuous development of their skills, productivity, and technology,” said Michael Reitermann, president, Molecular Imaging Division, Siemens Medical Solutions. "We offer a full spectrum of educational and marketing modules to help our customers develop and grow their practices, and gain greater awareness of payer positions on reimbursement.”

Molecular imaging biomarkers--small tracers that monitor biologic processes--enable the biologic processes of disease to be identified and understood. Results may help clinicians determine customized therapies for patients by pinpointing the active pathways in the disease progression. "As the technologies evolve, PETNet offers advanced products and services that optimize diagnostic accuracy, and help support business growth,” added Mr. Reitermann.





Related Links:
Siemens Medical Solutions
PETNet Pharmaceuticals

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Multi-Chamber Washer-Disinfector
WD 390
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: 123RF

Existing Cardiovascular Risk Calculators Predict Several Common Cancers

Cardiovascular risk calculators are embedded in primary and secondary care to estimate 10‑year risk of heart attack or stroke from factors such as age, body mass index, and smoking. Many of these same... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.